Oral and gum health and saliva markers in people with hepatitis B and D
Official title: Oral-Periodontal Evaluation and Assessment of Biomarkers in Oral Fluids in Patients With Hepatitis B+D Treated With Bulevirtide
Run by Research Center of Periodontal-Systemic Interactions · NCT07491848 · Data updated 2026-11-12
This project will test whether gum inflammation and specific saliva and gum-fluid markers differ in adults with hepatitis B and D—both those taking bulevirtide and those not—compared with healthy adults.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | Research Center of Periodontal-Systemic Interactions Academic / other |
| Locations | 2 sites (Craiova and 1 other locations) |
| Status | Recruiting |
| Started | February 15, 2026 |
| Main results expected | February 15, 2027 |
| Study ends | February 15, 2027 |
| Registry record updated | March 25, 2026 |
| Trial ID | NCT07491848 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults (age 18+) with confirmed hepatitis B and D co-infection—either receiving bulevirtide or not—or systemically healthy adults willing to undergo oral exams and saliva and gingival crevicular fluid collection.
✕Probably not a fit
People with other systemic diseases that affect periodontal health (for example uncontrolled diabetes or autoimmune conditions), recent oral or periodontal surgery within six months, pregnancy or lactation, or those unable to provide informed consent are unlikely to benefit or may be ineligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective case-control study will compare oral-periodontal clinical measures and targeted inflammatory biomarkers in saliva and gingival crevicular fluid across three groups: adults with hepatitis B+D on bulevirtide, adults with hepatitis B+D not on bulevirtide, and healthy controls. A specialist periodontist will perform standardized oral exams with photographs, and non-invasive saliva and crevicular fluid samples will be collected at baseline and at six months. Samples will be analyzed at the Immunology Laboratory of the University of Medicine and Pharmacy of Craiova and at the University of Amsterdam to quantify inflammatory mediators. Statistical analysis will examine associations between periodontal inflammation, oral biomarkers, and hepatitis B+D status and treatment.
Why it matters
Potential benefit: If successful, the work could identify oral biomarkers linked to hepatitis B+D and effects of bulevirtide, helping guide monitoring and targeted oral care for affected patients.
How similar studies have gone: Prior studies have linked oral inflammation and saliva biomarkers to systemic liver disease, but using these markers specifically in hepatitis B+D patients and in relation to bulevirtide treatment is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (≥18 years old) capable of providing informed consent. * For Hepatitis B+D groups: confirmed hepatitis B and D co-infection. * Bulevirtide group: receiving bulevirtide therapy as prescribed. * No Bulevirtide group: not receiving bulevirtide. * For Healthy Control group: systemically healthy adults without hepatitis B or D infection. * Willingness to undergo oral-periodontal examination, saliva and gingival crevicular fluid collection, and oral cavity photography. Exclusion Criteria: * Patients with other systemic diseases that could influence periodontal health (e.g., uncontrolled diabetes, autoimmune diseases). * Patients currently receiving other experimental therapies that may affect oral or systemic inflammation. * Pregnancy or lactation. * Inability or unwillingness to provide informed consent. * History of oral or periodontal surgery within the last 6 months that could affect measurements.
Where it's running
-
Clinical Emergency County Hospital Craiova
Craiova, Romania Recruiting -
University of Medicine and Pharmacy of Craiova
Craiova, Romania Recruiting
Study contacts
- Study coordinator: Petra Surlin, Professor
- Email: petra.surlin@umfcv.ro
- Phone: 0040745538483
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Association Between Periodontitis and Dry Eye Disease in Adults
This study tests whether periodontitis and dry eye disease are linked by comparing groups with and without each condition.
-
Periodontal Infection and Inflammatory Markers in Missed Abortion
Researchers will test whether gum infection and inflammation are linked to missed abortion in pregnant women with no major chromosomal problems.
-
Smoking, MFN1, and NLRP3 Levels in Gum Fluid Across Periodontal Health and Disease
This study tests whether smoking changes MFN1 and NLRP3 protein levels in the fluid around the gums for adults with or without periodontitis.
-
Dental Loupes vs. Dental Operating Microscope for Non-Surgical Periodontal Treatment
This study tests whether using dental loupes or a dental operating microscope makes non-surgical periodontal cleaning more effective for adults with periodontitis.
-
Boron, Oxidative Stress, and Inflammation in Periodontitis
This observational study compares boron levels and inflammation markers in saliva and gum tissue between people with periodontitis and healthy controls to see if boron relates to gum inflammation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.